Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
35°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rhythm Pharmaceuticals Inc
(NQ:
RYTM
)
42.61
+0.82 (+1.96%)
Streaming Delayed Price
Updated: 2:38 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Rhythm Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Analyst Expectations For Rhythm Pharmaceuticals's Future
February 22, 2024
Via
Benzinga
The Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Experts
January 04, 2024
Via
Benzinga
Analyst Expectations for Rhythm Pharmaceuticals's Future
December 07, 2023
Via
Benzinga
Rare Genetic Diseases Of Obesity-Focused Rhythm Pharma's Bardet-Biedl Syndrome Drug Meets Primary Goal In Pediatric Trial
December 06, 2023
During the R&D event for investors, Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) released new topline data from its Phase 3 pediatrics trial evaluating one year of setmelanotide in patients aged two and...
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Rhythm Pharmaceuticals: Here's What You Need To Know
October 10, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2023
August 02, 2023
Via
Benzinga
Rhythm Pharmaceuticals's Return On Capital Employed Overview
May 08, 2023
Via
Benzinga
Earnings Scheduled For February 22, 2024
February 22, 2024
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
Via
Benzinga
Preview: Rhythm Pharmaceuticals's Earnings
February 21, 2024
Via
Benzinga
Rhythm Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
January 25, 2024
Via
Benzinga
Earnings Scheduled For November 7, 2023
November 07, 2023
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
Via
Benzinga
A Preview Of Rhythm Pharmaceuticals's Earnings
May 01, 2023
Via
Benzinga
Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
August 01, 2023
Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 01, 2023
Via
Benzinga
Expert Ratings for Rhythm Pharmaceuticals
March 02, 2023
Via
Benzinga
Earnings Scheduled For March 1, 2023
March 01, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
Via
Benzinga
Rhythm Pharmaceuticals's Return On Capital Employed Overview
December 06, 2022
Via
Benzinga
Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday
August 01, 2023
U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...
Via
Benzinga
What Will Amgen Buy Next?
June 29, 2023
The biotech could pursue these two budget-friendly targets.
Via
The Motley Fool
3 Breakout Growth Stocks to Buy for the Long Haul
January 09, 2023
These three have had big-time share gains backed up by breakthrough science.
Via
The Motley Fool
20 Favorite Biotech & Medical Stocks For 2023
December 28, 2022
The way these stocks are setting up, many of them look great and will be at the forefront this coming year.
Via
Talk Markets
Biotech Stocks Well-Positioned For The Fourth Quarter
October 12, 2022
The path of interest rates is clearer for 2022 and the FED is closer to a pause early next year as it calibrates its response from a hammer approach so far.
Via
Talk Markets
Why ZW Data Action Technologies Jumped 37%; Here Are 71 Biggest Movers From Yesterday
September 16, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 15, 2022
Via
Benzinga
Why Adobe Is Trading Lower By 17%, Here Are 49 Stocks Moving In Thursday's Mid-Day Session
September 15, 2022
Gainers HeartBeam, Inc. (NASDAQ: BEAT) shares surged 58% to $1.96 after the company announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome...
Via
Benzinga
Why Is Rhythm Pharmaceuticals Stock Down Today?
September 15, 2022
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) shares are trading lower Thursday morning after the company priced its public offering of 4.8 million shares of common stock at $26 per share.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 15, 2022
Via
Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
September 15, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 15, 2022
Good morning! It's time for another dive into the biggest pre-market stock movers as we see why shares are moving Thursday morning!
Via
InvestorPlace
Arconic, Rhythm Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
September 15, 2022
U.S. stock futures traded higher this morning ahead of several economic reports. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.